Browse by UCL people
Group by: Type | Date
Number of items: 74.
2025
Gharibzadeh, Safoora;
Routen, Ash;
Razieh, Cameron;
Zaccardi, Francesco;
Lawson, Claire;
Gillies, Clare;
Heller, Simon;
... Khunti, Kamlesh; + view all
(2025)
Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
eClinicalMedicine
, 79
, Article 103005. 10.1016/j.eclinm.2024.103005.
![]() |
2024
Althobiani, MA;
Russell, AM;
Jacob, J;
Ranjan, Y;
Folarin, AA;
Hurst, JR;
Porter, JC;
(2024)
Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment.
Frontiers in Medicine
, 11
, Article 1296890. 10.3389/fmed.2024.1296890.
![]() |
![]() |
Althobiani, Malik A;
Ranjan, Yatharth;
Russell, Anne-Marie;
Jacob, Joseph;
Orini, Michele;
Sankesara, Heet;
Conde, Pauline;
... Folarin, Amos A; + view all
(2024)
Home monitoring to detect progression of interstitial lung disease: A prospective cohort study.
Respirology
10.1111/resp.14708.
![]() |
Althobiani, Malik A;
Shuttleworth, Rebecca;
Conway, John;
Dainton, Jonathan;
Duckworth, Anna;
Da Ponte, Ana Jorge;
Mandizha, Jessica;
... Russell, Anne-Marie; + view all
(2024)
Supporting self-management for patients with Interstitial Lung Diseases: Utility and acceptability of digital devices.
PLOS Digit Health
, 3
(1)
, Article e0000318. 10.1371/journal.pdig.0000318.
![]() |
Djukanović, Ratko;
Brinkman, Paul;
Kolmert, Johan;
Gomez, Cristina;
Schofield, James;
Brandsma, Joost;
Shapanis, Andy;
... U-BIOPRED study team; + view all
(2024)
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.
American Journal of Respiratory and Critical Care Medicine
, 210
(3)
288 -297.
10.1164/rccm.202310-1730OC.
![]() |
Jordon, Louise Helen;
Ganeshan, Balaji;
Nadeem, Iftikhar;
Hoy, Luke;
Mahdi, Noor;
Porter, Joanna C;
Groves, Ashley;
(2024)
Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.
BMJ OPEN
, 14
(5)
, Article e081103. 10.1136/bmjopen-2023-081103.
![]() |
Lord, JM;
Veenith, T;
Sullivan, J;
Sharma-Oates, A;
Richter, AG;
Greening, NJ;
McAuley, HJC;
... ISARIC4C investigators; + view all
(2024)
Accelarated immune ageing is associated with COVID-19 disease severity.
Immunity & Ageing
, 21
, Article 6. 10.1186/s12979-023-00406-z.
![]() |
Porter, Joanna C;
Ganeshan, Balaji;
Win, Thida;
Fraioli, Francesco;
Khan, Saif;
Rodriguez-Justo, Manuel;
Endozo, Raymond;
... Groves, Ashley M; + view all
(2024)
[¹⁸F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases.
Journal of Nuclear Medicine
, 65
(3)
, Article jnumed.123.266445. 10.2967/jnumed.123.266445.
![]() |
Whitehead, Alexander C;
Su, Kuan-Hao;
Emond, Elise C;
Biguri, Ander;
Brusaferri, Ludovica;
Machado, Maria;
Porter, Joanna C;
... Thielemans, Kris; + view all
(2024)
Data driven surrogate signal extraction for dynamic PET using selective PCA: time windows versus the combination of components.
Physics in Medicine & Biology
, 69
(17)
, Article 175008. 10.1088/1361-6560/ad5ef1.
![]() |
2023
Althobiani, Malik A;
Khan, Bilal;
Shah, Amar J;
Ranjan, Yatharth;
Mendes, Renata G;
Folarin, Amos;
Mandal, Swapna;
... Hurst, John R; + view all
(2023)
Clinicians' Perspectives of Wearable Technology to Detect and Monitor Exacerbations of Chronic Obstructive Pulmonary Disease: Mixed-Method Survey.
International Journal of Chronic Obstructive Pulmonary Disease
, 18
pp. 1401-1412.
10.2147/COPD.S405386.
![]() |
Althobiani, Malik A;
Ranjan, Yatharth;
Jacob, Joseph;
Orini, Michele;
Dobson, Richard James Butler;
Porter, Joanna C;
Hurst, John R;
(2023)
Evaluating a Remote Monitoring Program for Respiratory Diseases: Prospective Observational Study.
JMIR Formative Research
, 7
, Article e51507. 10.2196/51507.
![]() |
Brightling, CE;
Evans, RA;
Singapuri, A;
Smith, N;
Wain, LV;
Brightling, CE;
Evans, RA;
... Barker, RE; + view all
(2023)
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
The Lancet Respiratory Medicine
, 11
(11)
e93-e94.
10.1016/S2213-2600(23)00341-7.
![]() |
Chong, Deborah LW;
Mikolasch, Theresia A;
Sahota, Jagdeep;
Rebeyrol, Carine;
Garthwaite, Helen S;
Booth, Helen L;
Heightman, Melissa;
... Porter, Joanna C; + view all
(2023)
Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis.
American Journal of Physiology: Lung Cellular and Molecular Physiology
, 235
(4)
L487-L499.
10.1152/ajplung.00227.2022.
![]() |
Gudmundsson, Eyjolfur;
Zhao, An;
Mogulkoc, Nesrin;
van Beek, Frouke;
Goos, Tinne;
Brereton, Christopher J;
Veltkamp, Marcel;
... Jacob, Joseph; + view all
(2023)
Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis.
ERJ Open Research
, 9
(2)
, Article 00637-2022. 10.1183/23120541.00637-2022.
![]() |
Jackson, Callum;
Stewart, Iain D;
Plekhanova, Tatiana;
Cunningham, Peter S;
Hazel, Andrew L;
Al-Sheklly, Bashar;
Aul, Raminder;
... PHOSP-COVID Study Collaborative Group; + view all
(2023)
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
The Lancet Respiratory Medicine
10.1016/S2213-2600(23)00124-8.
(In press).
![]() |
![]() ![]() |
Leek, F;
Anderson, C;
Robinson, AP;
Moss, RM;
Porter, JC;
Garthwaite, HS;
Groves, AM;
... Thielemans, K; + view all
(2023)
Optimisation of the air fraction correction for lung PET/CT: addressing resolution mismatch.
EJNMMI Physics
, 10
, Article 77. 10.1186/s40658-023-00595-y.
![]() |
Maher, Toby M;
Avram, Cristina;
Bortey, Enoch;
Hart, Simon P;
Hirani, Nikhil;
Molyneux, Philip L;
Porter, Joanna C;
... Sciascia, Thomas; + view all
(2023)
Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis.
NEJM Evidence
, 2
(8)
10.1056/evidoa2300083.
![]() |
McAuley, Hamish JC;
Evans, Rachael A;
Bolton, Charlotte E;
Brightling, Christopher E;
Chalmers, James D;
Docherty, Annemarie B;
Elneima, Omer;
... PHOSP-COVID Study Collaborative Group; + view all
(2023)
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
EClinicalMedicine
, 57
, Article 101896. 10.1016/j.eclinm.2023.101896.
![]() |
Mikolasch, Theresia A;
George, Peter M;
Sahota, Jagdeep;
Nancarrow, Thomas;
Barratt, Shaney L;
Woodhead, Felix A;
Kouranos, Vasilis;
... Porter, Joanna C; + view all
(2023)
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosis.
EClinicalMedicine
, 55
, Article 101758. 10.1016/j.eclinm.2022.101758.
![]() |
Porter, JC;
Inshaw, J;
Solis, VJ;
Denneny, E;
Evans, R;
Temkin, MI;
De Vasconcelos, N;
... Papayannopoulos, V; + view all
(2023)
Anti-inflammatory therapy with nebulised dornase alfa in patients with severe COVID-19 pneumonia A Randomised Clinical Trial.
eLife
, 12
10.7554/eLife.87030.1.
(In press).
![]() |
Raman, B;
McCracken, C;
Cassar, MP;
Moss, AJ;
Finnigan, L;
Samat, AHA;
Ogbole, G;
... Bandula, S; + view all
(2023)
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
The Lancet Respiratory Medicine
, 11
(11)
pp. 1003-1019.
10.1016/S2213-2600(23)00262-X.
![]() |
![]() |
Stewart, Iain;
Jacob, Joseph;
George, Peter M;
Molyneaux, Philip L;
Porter, Joanna C;
Allen, Richard J;
Aslani, Shahab;
... Jenkins, R Gisli; + view all
(2023)
Residual Lung Abnormalities Following COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID Study.
American Journal of Respiratory and Critical Care Medicine
, 207
(6)
pp. 693-703.
10.1164/rccm.202203-0564OC.
![]() |
Whittington, Ashley;
Turner, Frances C;
Baark, Friedrich H;
Templeman, Sam S;
Kirwan, Daniela M;
Roufosse, Candice A;
Krishnan, Nitya M;
... Friedland, Jon A; + view all
(2023)
An acidic microenvironment in Tuberculosis increases extracellular matrix degradation by regulating macrophage inflammatory responses.
PLoS Pathogens
, 19
(7)
, Article e1011495. 10.1371/journal.ppat.1011495.
![]() |
Zhao, An;
Gudmundsson, Eyjolfur;
Mogulkoc, Nesrin;
van Moorsel, Coline;
Corte, Tamera J;
Vasudev, Pardeep;
Romei, Chiara;
... Jacob, Joseph; + view all
(2023)
Mortality surrogates in combined pulmonary fibrosis and emphysema.
European Respiratory Journal
, 63
(4)
, Article 2300127. 10.1183/13993003.00127-2023.
![]() |
2022
AlDalilah, Yazeed;
Ganeshan, Balaji;
Endozo, Raymond;
Bomanji, Jamshed;
Porter, Joanna C;
Machado, Maria;
Bertoletti, Linda;
... Fraioli, Francesco; + view all
(2022)
Filtration-histogram based texture analysis and CALIPER based pattern analysis as quantitative CT techniques in idiopathic pulmonary fibrosis: head-to-head comparison.
The British Journal of Radiology
10.1259/bjr.20210957.
(In press).
![]() |
![]() |
Banerjee, Susana;
Michalarea, Vasiliki;
Ang, Joo Ern;
Ingles Garces, Alvaro;
Biondo, Andrea;
Funingana, Ionut-Gabriel;
Little, Martin;
... Banerji, Udai; + view all
(2022)
A phase I trial of CT900, a novel α-folate receptor-mediated thymidylate synthase inhibitor, with expansion cohorts in patients with high grade serous ovarian cancer.
Clinical Cancer Research
10.1158/1078-0432.CCR-22-1268.
(In press).
![]() |
Daines, Luke;
Zheng, Bang;
Elneima, Omer;
Harrison, Ewen;
Lone, Nazir I;
Hurst, John R;
Brown, Jeremy S;
... Sheikh, Aziz; + view all
(2022)
Characteristics and risk factors for post-COVID breathlessness after hospitalisation for COVID-19.
ERJ Open Research
10.1183/23120541.00274-2022.
(In press).
![]() |
Horsley, Alex;
Brightling, Chris;
Davies, Jane;
Djukanovic, Ratko;
Heaney, Liam G;
Hussell, Tracy;
Marciniak, Stefan J;
... NIHR Respiratory Translational Research Collaboration, network; + view all
(2022)
Early-phase clinical trials in a pandemic: learning from the response to COVID-19.
The Lancet Respiratory Medicine
, 10
(7)
pp. 625-627.
10.1016/S2213-2600(22)00062-5.
![]() |
Horsley, Alex R;
Pearmain, Laurence;
Knight, Sean;
Schindler, Nick;
Wang, Ran;
Bennett, Miriam;
Robey, Rebecca C;
... Ho, Ling-Pei; + view all
(2022)
Large scale clinical trials: lessons from the COVID-19 pandemic.
BMJ Open Respiratory Research
, 9
(1)
, Article e001226. 10.1136/bmjresp-2022-001226.
![]() |
Mehta, Puja;
Hoyles, Rachel K;
Gunawardena, Harsha;
Gooptu, Bibek;
Choudhary, Nazia;
Heightmann, Melissa J;
Garthwaite, Helen;
... Denton, Christopher P; + view all
(2022)
Rheumatologists have an important role in the management of interstitial lung disease (ILD): a cross-speciality, multi-centre, U.K. perspective.
Rheumatology
10.1093/rheumatology/keac061.
![]() |
Mikolasch, TA;
Oballa, E;
Vahdati-Bolouri, M;
Jarvis, E;
Cui, Y;
Cahn, A;
Terry, RL;
... Porter, JC; + view all
(2022)
Mass spectrometry detection of inhaled drug in distal fibrotic lung.
Respiratory Research
, 23
(1)
, Article 118. 10.1186/s12931-022-02026-5.
![]() |
Parente-Pereira, AC;
Beatson, RE;
Davies, DM;
Hull, C;
Whilding, LM;
Porter, JC;
Maher, J;
(2022)
Generation and application of TGFβ-educated human Vγ9Vδ2 T cells.
STAR Protocols
, 3
(2)
, Article 101319. 10.1016/j.xpro.2022.101319.
![]() |
Porter, Joanna C;
Win, Thida;
Erlandsson, Kjell;
Thielemans, Kris;
Groves, Ashley M;
(2022)
Reply: Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control.
European Respiratory Journal
, 59
(3)
, Article 2103124. 10.1183/13993003.03124-2021.
![]() |
Whitehead, Alexander;
Su, Kuan-Hao;
Emond, Elise;
Biguri, Ander;
Machado, Maria;
Porter, Joanna;
Garthwaite, Helen;
... Thielemans, Kris; + view all
(2022)
Data Driven Surrogate Signal Extraction for Dynamic PET Using Selective PCA.
In:
Proceedings of the IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) 2022.
(pp. pp. 1-4).
Institute of Electrical and Electronics Engineers (IEEE)
![]() |
2021
Althobiani, MA;
Evans, RA;
Alqahtani, JS;
Aldhahir, AM;
Russell, AM;
Hurst, JR;
Porter, JC;
(2021)
Home monitoring of physiology and symptoms to detect Interstitial Lung Disease exacerbations and progression: a systematic review.
ERJ Open Research
, 7
(4)
10.1183/23120541.00441-2021.
(In press).
![]() |
![]() |
Chong, DLW;
Rebeyrol, C;
José, RJ;
Williams, AE;
Brown, JS;
Scotton, CJ;
Porter, JC;
(2021)
ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo.
Frontiers in Immunology
, 12
, Article 691957. 10.3389/fimmu.2021.691957.
![]() |
![]() |
Denneny, Emma K;
Porter, Joanna C;
(2021)
Drugs without benefits? Confronting the challenges of drug-induced interstitial lung disease.
Thorax
, 76
(12)
pp. 1172-1173.
10.1136/thoraxjnl-2021-217373.
![]() |
Denneny, EK;
Garthwaite, HS;
Heightman, MJ;
Porter, JC;
(2021)
A Role for Steroids in COVID-19 Associated Pneumonitis at Six-week Follow-up?
Annals of the American Thoracic Society
10.1513/AnnalsATS.202101-048LE.
(In press).
![]() |
Evans, RA;
McAuley, H;
Harrison, EM;
Shikotra, A;
Singapuri, A;
Sereno, M;
Elneima, O;
... PHOSP-COVID Collaborative Group, .; + view all
(2021)
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.
Lancet Respiratory Medicine
10.1016/S2213-2600(21)00383-0.
(In press).
![]() |
![]() |
Heightman, M;
Prashar, J;
Hillman, TE;
Marks, M;
Livingston, R;
Ridsdale, HA;
Bell, R;
... Banerjee, A; + view all
(2021)
Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals.
BMJ Open Respiratory Research
, 8
(1)
, Article e001041. 10.1136/bmjresp-2021-001041.
![]() |
![]() |
Mehta, P;
Bunker, CB;
Ciurtin, C;
Porter, JC;
Chambers, RC;
Papdopoulou, C;
Garthwaite, H;
... Denton, CP; + view all
(2021)
Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy.
The Lancet Infectious Diseases
, 21
(7)
p. 912.
10.1016/s1473-3099(21)00133-x.
![]() |
Porter, JC;
Win, T;
Erlandsson, K;
Fraioli, F;
Rashidnasab, A;
Holman, B;
Ganeshan, B;
... Groves, AM; + view all
(2021)
Measurement of hypoxia in the lung in IPF: an F-MISO PET CT study.
European Respiratory Journal
, 58
(4)
, Article 2004584. 10.1183/13993003.04584-2020.
![]() |
Ranjan, Y;
Althobiani, M;
Jacob, J;
Orini, M;
Dobson, R;
Porter, J;
Hurst, J;
(2021)
Issue in Remote Assessment of Lung Disease and Impact on Physical and Mental Health (RALPMH): Protocol for Prospective Observational Study.
JMIR Research Protocols
10.2196/28873.
(In press).
![]() |
![]() |
Thornton, A;
Fraioli, F;
Wan, S;
Garthwaite, HS;
Ganeshan, B;
Shortman, RI;
Endozo, R;
... Groves, AM; + view all
(2021)
Evolution of 18F-FDG-PET/CT findings in patients following COVID-19 pneumonia: An Initial Investigation.
Journal of Nuclear Medicine
10.2967/jnumed.121.262296.
(In press).
![]() |
![]() |
Tornling, G;
Batta, R;
Porter, JC;
Williams, B;
Bengtsson, T;
Parmar, K;
Kashiva, R;
... Raud, J; + view all
(2021)
Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial.
EClinicalMedicine
, 41
, Article 101152. 10.1016/j.eclinm.2021.101152.
![]() |
![]() |
Wild, JM;
Porter, JC;
Molyneaux, PL;
George, PM;
Stewart, I;
Allen, RJ;
Aul, R;
... Jenkins, RG; + view all
(2021)
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID).
BMJ Open Respiratory Research
, 8
(1)
, Article e001049. 10.1136/bmjresp-2021-001049.
![]() |
![]() |
2020
Chong, DLW;
Trinder, S;
Labelle, M;
Rodriguez-Justo, M;
Hughes, S;
Holmes, AM;
Scotton, CJ;
(2020)
Platelet-derived Transforming Growth Factor-β1 promotes keratinocyte proliferation in cutaneous wound healing.
Journal of Tissue Engineering and Regenerative Medicine
, 14
(4)
pp. 645-649.
10.1002/term.3022.
![]() |
![]() |
Denneny, E;
Sahota, J;
Beatson, R;
Thornton, D;
Burchell, J;
Porter, J;
(2020)
Mucins and their receptors in chronic lung disease.
Clinical & Translational Immunology
, 9
, Article e1120. 10.1002/cti2.1120.
![]() |
![]() |
Drake, TM;
Docherty, AB;
Harrison, EM;
Quint, JK;
Adamali, H;
Agnew, S;
Babu, S;
... ISARIC4C Investigators; + view all
(2020)
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study.
American Journal of Respiratory and Critical Care Medicine
10.1164/rccm.202007-2794OC.
(In press).
![]() |
![]() |
Duarte, AC;
Porter, J;
Leandro, MJ;
(2020)
Bronchiectasis in rheumatoid arthritis. A clinical appraisial.
Joint Bone Spine
, 87
(5)
pp. 419-424.
10.1016/j.jbspin.2019.12.006.
![]() |
Dushianthan, A;
Clark, H;
Madsen, J;
Mogg, R;
Matthews, L;
Berry, L;
De la Serna, JB;
... Grocott, MPW; + view all
(2020)
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
Trials
, 21
, Article 1014. 10.1186/s13063-020-04944-5.
![]() |
![]() |
Emond, E;
Bousse, A;
Machado, M;
Porter, J;
Groves, A;
Hutton, B;
Thielemans, K;
(2020)
Effect of Attenuation Mismatches in Time of Flight PET Reconstruction.
Physics in Medicine & Biology
, 65
, Article 085009. 10.1088/1361-6560/ab7a6f.
![]() |
![]() |
Khawaja, AA;
Chong, DLW;
Sahota, J;
Mikolasch, TA;
Pericleous, C;
Ripoll, VM;
Booth, HL;
... Porter, JC; + view all
(2020)
Identification of a Novel HIF-1α-α_{M}β_{2} Integrin-NET Axis in Fibrotic Interstitial Lung Disease.
Frontiers in Immunology
, 11
, Article 2190. 10.3389/fimmu.2020.02190.
![]() |
![]() |
Maher, TM;
Simpson, JK;
Porter, JC;
Wilson, FJ;
Chan, R;
Eames, R;
Cui, Y;
... Vahdati-Bolouri, M; + view all
(2020)
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor.
Respiratory Research
, 21
(1)
, Article 75. 10.1186/s12931-020-01339-7.
![]() |
![]() |
Mandal, S;
Barnett, J;
Brill, SE;
Brown, JS;
Denneny, EK;
Hare, SS;
Heightman, M;
... ARC Study Group, .; + view all
(2020)
'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19.
Thorax
10.1136/thoraxjnl-2020-215818.
(In press).
![]() |
![]() |
Mann, ER;
Menon, M;
Knight, SB;
Konkel, JE;
Jagger, C;
Shaw, TN;
Krishnan, S;
... Hussell, T; + view all
(2020)
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.
Science Immunology
, 5
(51)
, Article eabd6197. 10.1126/sciimmunol.abd6197.
![]() |
![]() |
Mehta, P;
Porter, JC;
Chambers, RC;
Isenberg, DA;
Reddy, V;
(2020)
B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
The Lancet Rheumatology
, 2
(10)
e589-e590.
10.1016/S2665-9913(20)30270-8.
![]() |
Mehta, P;
Porter, JC;
Manson, JJ;
Isaacs, JD;
Openshaw, PJM;
McInnes, IB;
Summers, C;
(2020)
Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities.
The Lancet Respiratory Medicine
, 8
(8)
pp. 822-830.
10.1016/S2213-2600(20)30267-8.
![]() |
Wilson, AM;
Clark, AB;
Cahn, T;
Chilvers, ER;
Fraser, W;
Hammond, M;
Livermore, DM;
... Whyte, M; + view all
(2020)
Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis. The EME-TIPAC Randomized Clinical Trial.
JAMA
, 324
(22)
pp. 2282-2291.
10.1001/jama.2020.22960.
|
2019
Bardin, P;
Foussignière, T;
Rousselet, N;
Rebeyrol, C;
Porter, JC;
Corvol, H;
Tabary, O;
(2019)
miR-636: A Newly-Identified Actor for the Regulation of Pulmonary Inflammation in Cystic Fibrosis.
Frontiers In Immunology
, 10
, Article 2643. 10.3389/fimmu.2019.02643.
![]() |
![]() |
Emond, EC;
Bousse, A;
MacHado, M;
Porter, J;
Erlandsson, K;
Groves, AM;
Hutton, BF;
(2019)
Respiratory Motion Correction in Dynamic PET with a Single Attenuation Map.
In:
Proceedings of 2019 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC).
IEEE: Manchester, UK.
![]() |
![]() |
Fraioli, F;
Lyasheva, M;
Porter, JC;
Bomanji, J;
Shortman, RI;
Endozo, R;
Wan, S;
... Groves, AM; + view all
(2019)
Synergistic application of pulmonary 18F-FDG PET/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF).
European Journal of Nuclear Medicine and Molecular Imaging
, 46
(10)
pp. 2023-2031.
10.1007/s00259-019-04386-5.
![]() |
![]() |
Khawaja, AA;
Pericleous, C;
Ripoll, VM;
Porter, JC;
Giles, IP;
(2019)
Autoimmune rheumatic disease IgG has differential effects upon neutrophil integrin activation that is modulated by the endothelium.
Scientific Reports
, 9
, Article 1283. 10.1038/s41598-018-37852-5.
![]() |
![]() |
2018
Brilha, S;
Chong, DLW;
Khawaja, AA;
Ong, CWM;
Guppy, NJ;
Porter, JC;
Friedland, JS;
(2018)
Integrin alpha 2 beta 1 Expression Regulates Matrix Metalloproteinase-1-Dependent Bronchial Epithelial Repair in Pulmonary Tuberculosis.
Frontiers in Immunology
, 9
, Article 1348. 10.3389/fimmu.2018.01348.
![]() |
![]() |
Fox, KA;
Kirwan, DE;
Whittington, AM;
Krishnan, N;
Robertson, BD;
Gilman, RH;
López, JW;
... Friedland, JS; + view all
(2018)
Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.
American Journal of Respiratory and Critical Care Medicine
, 198
(2)
pp. 245-255.
10.1164/rccm.201710-2102OC.
![]() |
![]() |
Wicks, EC;
Menezes, LJ;
Barnes, A;
Mohiddin, SA;
Sekhri, N;
Porter, JC;
Booth, HL;
... Elliott, PM; + view all
(2018)
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
European Heart Journal: Cardiovascular Imaging
, 19
(7)
pp. 757-767.
10.1093/ehjci/jex340.
![]() |
Win, T;
Screaton, NJ;
Porter, JC;
Ganeshan, B;
Maher, TM;
Fraioli, F;
Endozo, R;
... Groves, AM; + view all
(2018)
Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).
European Journal of Nuclear Medicine and Molecular Imaging
, 45
(5)
pp. 806-815.
10.1007/s00259-017-3917-8.
![]() |
![]() |
2017
Brilha, S;
Wysoczanski, R;
Whittington, AM;
Friedland, JS;
Porter, JC;
(2017)
Monocyte Adhesion, Migration, and Extracellular Matrix Breakdown Is Regulated by Integrin αVβ3 in Mycobacterium tuberculosis Infection.
The Journal of Immunology
, 199
(3)
pp. 982-991.
10.4049/jimmunol.1700128.
![]() |
![]() |
Mikolasch, TA;
Garthwaite, HS;
Porter, JC;
(2017)
Update in diagnosis and management of interstitial lung disease.
Clinical Medicine
, 17
(2)
pp. 146-153.
10.7861/clinmedicine.17-2-146.
![]() |
Siddharthan, T;
Grigsby, M;
Miele, CH;
Bernabe-Ortiz, A;
Miranda, JJ;
Gilman, RH;
Wise, RA;
... Checkley, W; + view all
(2017)
Prevalence and risk factors of restrictive spirometry in a cohort of Peruvian adults.
The International Journal of Tuberculosis and Lung Disease
, 21
(9)
pp. 1062-1068.
10.5588/ijtld.17.0101.
![]() |
2016
Garthwaite, HS;
Porter, JC;
(2016)
Biologic treatments for pulmonary involvment in rheumatic disease.
In: Isenberg, DA and Ciurtin, C, (eds.)
Biologics in Rheumatology: New Developments, Clinical Uses and Health Implications.
(pp. 171-182).
Nova Science Publishers: New York, NY, USA.
![]() |
Mikolasch, TA;
Garthwaite, HS;
Porter, JC;
(2016)
Update in diagnosis and management of interstitial lung disease.
Clinical Medicine
, 16
(Suppl 6)
s71-s78.
10.7861/clinmedicine.16-6-s71.
![]() |
2013
Win, T;
Thomas, BA;
Lambrou, T;
Hutton, BF;
Screaton, NJ;
Porter, JC;
Maher, TM;
... Groves, AM; + view all
(2013)
Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.
European Journal of Nuclear Medicine and Molecular Imaging
, 41
(2)
337- 342.
10.1007/s00259-013-2514-8.
![]() |
![]() |
2009
Porter, J.C.;
Hall, A.;
(2009)
Epithelial ICAM-1 and ICAM-2 regulate the egression of human T cells across the bronchial epithelium.
The FASEB Journal
, 23
(2)
pp. 492-502.
10.1096/fj.08-115899.
![]() |
![]() |